About US
Contact us
-
Pfizer partner CStone explores sale as US path blocked, Chinese competition heats up: BloombergA Pfizer cancer drug partner in China is considering a sale as the biotech’s commercial path in the U.S. looks uncertain and competition in its home country intensifies. CStone Pharmaceuticals2022/7/18
-
Ex-Novartis sales rep claims discrimination, retaliation led to her firing after she reported misconductA former Novartis sales representative has accused the company and two of her former supervisors of wrongfully firing her after she blew the whistle on a co-worker who allegedly falsified records.2022/7/18
-
BeiGene, Novartis' PD-1 delay; China's latest VBP; A Pfizer partner for sale?BeiGene and Novartis' PD-1 inhibitor was delayed at the FDA as the agency couldn't conduct inspections in China. Big Pharma's off-patent drugs once again lost major supply contracts in China's latest2022/7/15
-
J&J lambasts Sanofi for Zantac marketing claims just as its Icy Hot pain patch campaign faces scrutinySanofi’s legal team was handed a double whammy this week (and may want a word with its marketing team) as two of the French pharma’s products have come under fire. First up, Sanoficaught the ir2022/7/15
-
AstraZeneca to build production facility in China for COPD inhaler BreztriAstraZeneca plans to build a manufacturing facility in Qingdao, China, to produce its Breztri aerosol inhalant COPD treatment, which was recently added to the country’s National Reimbursement Drug Li2022/7/13
-
Pfizer's blockbuster rare disease med Vyndaqel hits supply snag in Korea thanks to quality problem: reportFollowing recent recalls of blood pressure medicines in North America, Pfizer has run into another drug manufacturing problem—this time in Asia. Pfizer halted the supply of rare disease med Vyn2022/7/13
-
Enhertu's standing ovation; Tessa's $126M CAR-T financing; Samsung's manufacturing dealAstraZeneca and Daiichi Sankyo's Enhertulooked on track to open a new breast cancer category: HER2-low. Singapore's Tessa Therapeutics grabbed $126 million in a series A to advance its CAR-T programs2022/7/11
-
Sanofi union members set strike date in Korea as wage negotiations stall: reportFed up with a low salary increase, unionized Sanofi workers in South Korea have threatened to go on strike. The workers will strike next month after failing to reach an agreement on a new wage2022/7/11
-
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: BloombergFor months, the industry has waited patiently as Novartis mulls the fate of its $25 billion generics arm. Now, it appears a spinoff could be in the cards. Staring down a tough market for a pote2022/7/5
-
Astellas' gene therapy setback and new partnerships; Fujifilm's $1.6B expansionAstellaswas hit with another gene therapy clinical hold, but the Japanese pharma signed two partnerships focused on novel antibody-drug conjugate technology and undruggable targets. Fujifilm is pouri2022/7/5